Researchers have found that those people who were exposed to high levels of air pollution for three months are at a higher risk of high blood sugar (glucose) levels and cardiovascular diseases (CVD), especially in patients of diabetes.
The study was conducted between 2003 and 2012 on more than 73,000 adults in Southern Israel.
The senior author of the study was Dr. Victor Novack MD, Ph.D., Soroka University Medical Center and Ben-Gurion University in Beer Sheva, Israel. The study was published in the Journal of Clinical Endocrinology & Metabolism.
Meena Chhabra, a Delhi based diabetologist says that the number of patients of type 1 diabetes (T1D) among children has risen from 1% to 5% during the last couple of years in India is due to obesity and poor diet.
The symptoms of type 1 diabetes (T1D) are the increase in the urination, hunger, thirst, infections and fatigue.
Type 1 diabetes (T1D) usually starts at a young age and type 2 diabetes (T2D) starts in adulthood.
The new platform can encourage patients to talk about their hypoglycemia and to take the guidance.
A study by WellDoc shows that a large percentage of patients of type 2 diabetes (T2D) are using the BlueStar mobile App and most of them have sent the reports from the mobile App to their care team.
The blood glucose monitor from LifeScan (Diagnostic Systems Manufacturer) is going to be integrated with the BlueStar mobile App. BlueStar mobile App is free with a prescription.
The BlueStar mobile App can provide health management tools and real-time diabetes management guidance. The BlueStar mobile App can provide actionable information and reports with data (blood glucose levels).
The researchers from the Nottingham Trent University and Cardiff University have developed a new diagnostic tool for the prediction of the onset of diabetes. They have developed a sensor which can trap the specific molecules in the blood which can give the signal for the onset of diabetes within five years.
Those people who are at the risk of diabetes can get the opportunity to change the diet and lifestyle.
The prototype model and the trial were yet to take place. But the team is planning to bring the device into the market within two to three years.
A study by Ai Kubo (Epidemiologist) shows early development of puberty in a daughter (2.5 times more likely) is due to obesity and diabetes during pregnancy of the mother.
This outcome is based on 421 girls and their mothers in Northern California. The author says that understanding the cause of early onset of puberty is the key in the development of the prevention strategy. The following are the increased adverse health risks with early puberty.
The study was published in the American Journal of Epidemiology.
A patient of diabetes is at double risk of depression. Dr. Sherita Golden at the Johns Hopkins University School of Medicine, says that cortisol, a stress hormone will be produced in the body due to depression.
Dr. David K C Cooper during the 76th scientific session of the American Diabetes Association (ADA) said that they performed approximately 1000 islets transplantation for patients with type 1 diabetes (T1D) during the last decade.
But the problem with the islets transplantation is that there is a huge demand from the patients of type 1 diabetes. The researchers have conducted a long-term trial on genetically modified islets to non-humans. The long-term trial was successful.
The researchers say that it is possible to transplant the islets of a pig to a patient suffering from type 1 diabetes (T1D) for the prevention of diabetes-related complications.
Dr. Chad A Cowan (Harvard Stem Cell Institute) and his colleagues have produced a new set of insulin-producing beta cells from the lab-grown stem cells. The following are the difficulties with the islets transplantation.
Producing islet cells in the laboratory and transplanting them into the human body by protecting them against the immune system is called the Regenerative medicine.
A study at the UBC Okanagan shows that a prolonged and overuse of antibiotics can accelerate the disruption of gut bacteria. The disruption of gut bacteria can lead to the onset of type 1 diabetes (T1D).
They say that the events in the early life are critical and the use of antibiotics will change the normal development of gut and subsequently the development of a healthy body.
The study shows a link between bacteria, the immune system of the body and the risk of type 1 diabetes (T1D).
The researchers say that a further study was required to identify the bacteria that can protect the body against type 1 diabetes (T1D). The study may help us in the development of specific antibiotics in the future. The study was published in the ISME Journal (Nature Group).
A study at Helsinki, Finland shows that patients with type 2 diabetes (T2D) can use prescription drug Tradjenta (linagliptin), used along with diet and exercise to lower the blood sugar levels. This medicine is not intended for patients with type 1 diabetes (T1D) or to patients suffering from diabetic ketoacidosis.
Tradjenta (once in a day) do not require dosage adjustment irrespective of the renal function. The side effects are a sore throat, stuffy nose, cough and diarrhoea (or diarrhea).
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.